The previous result found that ERBB2 (or HER2) can be cleaved by proteases, such as ADAM10, in HER2-overexpressing breast cancer cells [15,16,17,18,19,20,21,22,23]. This evidence concerns the gene ERBB2 and breast carcinoma.